HX575: established biosimilarity in the treatment of renal anemia and 10 years of clinical experience

• Egile Nagusiak: Dellanna F (Egilea), Goldsmith D (Egilea), Krendyukov A (Egilea), Seidl A (Egilea), Höbel N (Egilea), Combe C (Egilea)
• Formatua: Liburua
• Argitaratua: Dove Medical Press, 2017-12-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Frank Dellanna,1 David Goldsmith,2 Andriy Krendyukov,3 Andreas Seidl,4 Nadja Höbel,5 Christian Combe6,7 1MVZ Davita Rhein-Ruhr, Düsseldorf, Germany; 2Division of Nephrology, Guy’s and St Thomas’ Hospitals, London, UK; 3Hematology/Nephrology, Hexal AG, Holzkirchen, 4Technical Development Biosimilars,...